OnDosis AB

OnDosis is an AstraZeneca spin-off founded in 2017, headquartered at Gothenburg's BioVentureHub, developing a smart drug delivery platform for personalized and connected dosing. Its core technology, the Dosage Manager, is a connected handheld device delivering customizable, easily adjusted doses of oral medicines. Target indications: ADHD, pain management and immunosuppression for organ transplants. Raised $14.5M.